NEMESIS BIOSCIENCE
Nemesis Bioscience is a UK-based biopharmaceutical company developing products to resurrect anti-microbial therapies made ineffective by increasing microbial resistance. The company develops Nemesis Symbiotics that will make existing antibiotics work again, prevent the spread of resistance genes, and so also protect the efficacy of new antibiotics. The technology is applicable to all antibiotic classes, all known resistance mechanisms and all bacteria. Other applications include reduction of chemotherapeutic toxicity, inactivation of virulence factors, and in vivo synthesis of biofuels and therapeutics. The company was awarded the King’s College, Cambridge Entrepreneurship Award for 2014 and has filed patent applications internationally on its inventions.
NEMESIS BIOSCIENCE
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2014-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.nemesisbio.com
Total Employee:
1+
Status:
Active
Contact:
+4401223804075
Email Addresses:
[email protected]
Total Funding:
1000 K GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Current Employees Featured
Founder
Investors List
Future Planet Capital
Future Planet Capital investment in Seed Round - Nemesis Bioscience
Mark McCamish
Mark McCamish investment in Seed Round - Nemesis Bioscience
Development Bank of Wales
Development Bank of Wales investment in Seed Round - Nemesis Bioscience
UK Innovation & Science Seed Fund
UK Innovation & Science Seed Fund investment in Seed Round - Nemesis Bioscience
Development Bank of Wales
Development Bank of Wales investment in Seed Round - Nemesis Bioscience
Official Site Inspections
http://www.nemesisbio.com
- Host name: mail.domain-holding.co.uk
- IP address: 213.171.195.105
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Nemesis Bioscience"
Nemesis Bioscience - Crunchbase Company Profile
Nemesis Bioscience is a UK-based biopharmaceutical company developing products to resurrect anti-microbial therapies made ineffective by increasing microbial resistance. The company develops Nemesis Symbiotics that will …See details»
Nemesis Bioscience - Craft
Nemesis Bioscience is a biopharmaceutical company developing DNA therapeutics administered before antibiotics to inactivate resistance in bacterial pathogens. It makes existing antibiotics …See details»
Nemesis Biosciences Ltd.: Drug pipelines, Patents, Clinical trials ...
Explore Nemesis Biosciences Ltd. with its drug pipeline, therapeutic area, technology platform, 1 news, Disease Domain:Infectious Diseases, Technology Platform ...See details»
Nemesis Bioscience - Products, Competitors, Financials, Employees ...
Nemesis Bioscience is a biopharmaceutical company that operates in the biotechnology industry. Use the CB Insights Platform to explore Nemesis Bioscience's full profile.See details»
Nemesis Bioscience - PitchBook
Developer of anti-microbial therapies designed to inactivate resistance in bacterial pathogens.See details»
Conrad LICHTENSTEIN | Chief Scientific Officer | PhD - ResearchGate
I am Chief Scientific Officer of Nemesis Bioscience Ltd ( nemesisbio.com ), a biotech start-up I co-founded in 2014 with Drs Frank Massam and Gi Mikawa with seed funding from Finance Wales...See details»
NEMESIS BIOSCIENCE LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for NEMESIS BIOSCIENCE LTD of CAMBRIDGE. Get the latest business insights from Dun & Bradstreet.See details»
Nemesis Bioscience | VentureRadar
Website: http://www.nemesisbio.com Develops DNA therapeutics, called Nemesis Symbiotics, that inactivate antibiotic resistance in bacteria, allowing traditional antibiotics to effectively kill …See details»
Nemesis Bioscience - UKI2S
Nemesis Bioscience was founded in 2014 to address the global threat posed by increasing bacterial resistance to commonly used antibiotics.See details»
Nemesis Bioscience Ltd. - life-sciences-europe.com
Aug 3, 2014 · Upcoming Events. ESGCT 2024 Rome; iGEM 2024 Grand Jamboree Paris; Medtech Congress 2024 Courroux (CH) BioCentury-BayHelix China Healthcare Summit 2024 …See details»
Nemesis Bioscience awarded €2m EIC accelerator grant
Jul 19, 2022 · In a two-year, EIC funded programme, Nemesis will work with Newcastle University to demonstrate that Transmids©, delivered by commensal bacterial donors, can decolonise …See details»
Nemesis Bioscience Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for Nemesis Bioscience. See Nemesis Bioscience company profile and funding data.See details»
Nemesis Bioscience - Contacts, Employees, Board Members
We're working on getting contact data for Nemesis Bioscience. Find more contact data in Search! Nemesis Bioscience has 5 current employee profiles, including Chairman Alastair Riddell. …See details»
Nemesis Bioscience - VentureRadar
Website: http://www.nemesisbio.com Develops DNA therapeutics, called Nemesis Symbiotics, that inactivate antibiotic resistance in bacteria, allowing traditional antibiotics to effectively kill …See details»
Nemesis Bioscience - Bacteriophage.news
May 22, 2021 · Nemesis Bioscience is a biopharmaceutical company developing Nemesis Symbiotics©; a DNA therapeutics administered before antibiotics to inactivate resistance in …See details»
Nemesis Bioscience - Company Profile - Tracxn
Nov 21, 2024 · Developer of therapeutics to reverse microbial resistance to antibiotics. The company has Nemesis Transmid technology that uses multiplexed programmable RNA-guided …See details»
Nemesis: This biopharmaceutical company | Octopus Ventures
Oct 25, 2019 · Frank Massam, PhD and Professor Conrad Lichtenstein, PhD are co-founders of Nemesis Bioscience. This biopharmaceutical company is developing DNA therapeutics to …See details»
Nemesis Bioscience wins King’s College Entrepreneurship Award
Jan 27, 2015 · Nemesis Bioscience Ltd (Cambridge, UK) announced today that it has been awarded an Entrepreneurship Award by King’s College, Cambridge.See details»
Nemesis Bioscience - Alien Technology Transfer
Nemesis Bioscience is an early-stage biopharmaceutical company developing Transmids©, DNA therapeutics administered before or with antibiotics to inactivate resistance in bacterial …See details»
Nemesis - Crunchbase Company Profile & Funding
Nemesis provides bio and medical device vendors and service providers with Intelligent biosignal processing solutions. Nemesis has technologies like biosensors, bio-signal processing, and …See details»